CRISPR Technology — Current Affairs 2026
Current Affairs Connections
India's First Gene-Edited Mustard Variety Shows Promise for Enhanced Yield and Oil Content
Early 2024Indian agricultural research institutions, supported by the Department of Biotechnology (DBT), have reported significant progress in developing gene-edited mustard varieties using CRISPR technology. These varieties aim to enhance oil content and yield, crucial for reducing India's edible oil import dependency. Unlike traditional Genetically Modified (GM) crops that often involve inserting foreign genes, these gene-edited crops typically involve precise modifications to existing genes, potentially easing regulatory pathways. This development underscores India's commitment to leveraging advanced biotechnology for food security and agricultural self-reliance, aligning with the National Mission on Biotechnology.
UPSC Angle: This highlights the practical application of CRISPR in Indian agriculture, its potential impact on food security and economy, and the evolving regulatory landscape for gene-edited crops versus traditional GM crops. It's relevant for GS-3 Science & Technology, Agriculture, and Economy.
Global Push for Ethical Governance of Heritable Human Genome Editing Intensifies Post-He Jiankui
Ongoing 2024-2025Following the 2018 He Jiankui controversy, international bodies like the WHO and UNESCO continue to advocate for a global moratorium on heritable human genome editing (germline editing). Recent discussions in 2024-2025 focus on establishing robust international governance mechanisms, including registries for clinical trials, independent oversight bodies, and public engagement strategies. The debate extends to balancing therapeutic potential for severe genetic diseases with profound ethical concerns regarding human dignity, equity, and the potential for 'designer babies.' India's ICMR guidelines explicitly prohibit germline editing, aligning with this global ethical consensus.
UPSC Angle: This hook is vital for GS-4 Ethics, GS-2 Governance, and GS-3 Science & Technology. It emphasizes the ethical dilemmas, the need for international cooperation in scientific regulation, and India's stance on a highly sensitive biotechnological frontier. Aspirants should be prepared to discuss the ethical implications and policy responses.
CRISPR-Based Diagnostics Gain Traction for Rapid Disease Detection in Remote Areas
Late 2023 - Mid 2024Building on the success of CRISPR diagnostics like SHERLOCK and DETECTR during the COVID-19 pandemic, researchers are now adapting these platforms for rapid, point-of-care detection of other infectious diseases (e.g., tuberculosis, dengue, malaria) and even early cancer biomarkers. Efforts are focused on making these tests more affordable, portable, and user-friendly for deployment in resource-limited settings, including rural and remote areas of India. This involves developing paper-based assays and smartphone-integrated readers. This innovation promises to revolutionize public health surveillance and early disease intervention.
UPSC Angle: Relevant for GS-2 Health, GS-3 Science & Technology. It showcases the diagnostic potential of CRISPR beyond gene editing, its role in public health infrastructure, and its applicability in addressing health disparities in India. Focus on how technology can bridge healthcare gaps.